Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.5M Buy
122,804
+13,000
+12% +$4.45M 0.29% 61
2026
Q1
$38.6M Buy
109,804
+3,051
+3% +$1.09M 0.32% 56
2025
Q4
$34.9M Buy
106,753
+480
+0.5% +$152K 0.29% 60
2025
Q3
$29M Sell
106,273
-165
-0.2% -$47.9K 0.26% 76
2025
Q2
$29.7M Buy
106,438
+4,055
+4% +$1.15M 0.28% 64
2025
Q1
$31.9M Sell
102,383
-155
-0.2% -$45.8K 0.35% 54
2024
Q4
$26.7M Sell
102,538
-9,141
-8% -$2.71M 0.27% 65
2024
Q3
$36M Buy
111,679
+171
+0.2% +$55.9K 0.35% 52
2024
Q2
$34.8M Buy
111,508
+3,428
+3% +$1.01M 0.35% 47
2024
Q1
$30.7M Sell
108,080
-72
-0.1% -$21.1K 0.34% 55
2023
Q4
$31.1M Sell
108,152
-555
-0.5% -$151K 0.38% 50
2023
Q3
$29.2M Buy
108,707
+4,891
+5% +$1.22M 0.38% 48
2023
Q2
$23M Buy
103,816
+5,565
+6% +$1.29M 0.3% 61
2023
Q1
$23.8M Buy
98,251
+2,496
+3% +$613K 0.36% 53
2022
Q4
$25.1M Buy
95,755
+73
+0.1% +$19.6K 0.42% 45
2022
Q3
$21.6M Sell
95,682
-454
-0.5% -$110K 0.39% 47
2022
Q2
$23.4M Buy
96,136
+6,437
+7% +$1.58M 0.41% 49
2022
Q1
$21.7M Buy
89,699
+12,458
+16% +$2.86M 0.34% 58
2021
Q4
$17.4M Sell
77,241
-1,098
-1% -$232K 0.32% 62
2021
Q3
$16.7M Buy
78,339
+13
+0% +$2.99K 0.34% 59
2021
Q2
$19.1M Buy
78,326
+13,769
+21% +$3.39M 0.39% 53
2021
Q1
$16.1M Buy
64,557
+7,787
+14% +$1.86M 0.43% 49
2020
Q4
$13.1M Buy
56,770
+7,900
+16% +$1.82M 0.41% 50
2020
Q3
$12.4M Buy
48,870
+5,325
+12% +$1.32M 0.52% 39
2020
Q2
$10.3M Sell
43,545
-16,732
-28% -$3.82M 0.53% 39
2020
Q1
$12.6M Sell
60,277
-2,301
-4% -$503K 0.56% 36
2019
Q4
$15.1M Sell
62,578
-3,649
-6% -$804K 0.53% 36
2019
Q3
$12.8M Buy
66,227
+21,753
+49% +$4.18M 0.47% 41
2019
Q2
$8.2M Buy
44,474
+2,799
+7% +$501K 0.47% 42
2019
Q1
$7.92M Buy
41,675
+3,697
+10% +$706K 0.51% 42
2018
Q4
$7.39M Buy
37,978
+3,061
+9% +$597K 0.6% 35
2018
Q3
$7.24M Buy
34,917
+4,451
+15% +$877K 0.55% 38
2018
Q2
$5.62M Buy
30,466
+9,469
+45% +$1.67M 0.53% 39
2018
Q1
$3.58M Buy
20,997
+522
+3% +$95.8K 0.52% 41
2017
Q4
$3.56M Sell
20,475
-143
-0.7% -$25.3K 0.56% 39
2017
Q3
$3.84M Buy
20,618
+415
+2% +$73.5K 0.65% 34
2017
Q2
$3.48M Buy
20,203
+5,033
+33% +$819K 0.63% 32
2017
Q1
$2.49M Buy
15,170
+5,598
+58% +$930K 0.63% 32
2016
Q4
$1.4M Buy
+9,572
New +$1.44M 0.66% 32

Other funds holding AMGN

IFM Investors's AMGN Position: Q2 2026 in Review

IFM Investors increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $4.45M and bringing the position to 122,804 shares worth $44.5M. The position accounts for 0.29% of the portfolio, ranked #61.

IFM Investors first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. 958 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • IFM Investors held 122,804 shares of Amgen worth $44.5M as of Q2 2026.
  • IFM Investors bought 13,000 Amgen shares in Q2 2026, an estimated $4.45M.
  • Amgen made up 0.29% of IFM Investors's portfolio in Q2 2026, its #61 holding.
  • IFM Investors first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
  • 958 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.